Skip to main content

ARTIVION, INC. insider trading

CRYNYSE
$15.43-0.42 (-2.65%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Apr 28, 2026 to Oct 2, 2026. Price (-38.2%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

    AI Activity Analysis

    Premium
    Coming soonAI reads of insider activity will appear here for Premium accounts.

    Insider activity

    Fromto
    CompanyInsider / roleActionΔOwnAvg priceAmount
    CRYAndrew M. GreenSVP, Regulatory and QualityOpen market sell$287K-22.2%$24.97$287KSep 10, 2026Sep 11, 2026
    CRYAndrew M. GreenSVP, Regulatory and QualityOpen market sell$38.8K-2.8%$26.02$38.8KSep 3, 2026Sep 4, 2026
    CRYAndrew M. GreenSVP, Regulatory and QualityOpen market sell$177K-10.9%$27.27$177KSep 2, 2026Sep 4, 2026
    CRYJames P. MackinPresident & CEOOpen market sell$2.03M-7.4%$28.96$2.03MAug 19, 2026Aug 20, 2026
    CRYAndrew M. GreenSVP, Regulatory and QualityOpen market sell$17.6K-1.0%$28.55$17.6KAug 14, 2026Aug 17, 2026
    CRYLance A. BerryEVP, COO, CFO & TreasurerOpen market sell$20.4K-0.3%$28.55$20.4KAug 14, 2026Aug 17, 2026
    CRYJean F. HollowaySVP, General CounselOpen market sell$27.8K-0.5%$28.49$27.8KAug 12, 2026Aug 12, 2026
    CRYJean F. HollowaySVP, General CounselOpen market sell$341K-4.6%$38.00$341KMar 4, 2026Mar 4, 2026
    CRYAmy HortonVP, Chief Accounting OfficerOpen market sell$34K-0.6%$37.78$34KMar 3, 2026Mar 4, 2026
    CRYJean F. HollowaySVP, General CounselOpen market sell$145K-1.9%$37.78$145KMar 3, 2026Mar 4, 2026
    CRYMarshall S. StantonSVP, Clinical & MD AffairOpen market sell$81.2K-3.5%$37.78$81.2KMar 3, 2026Mar 4, 2026
    CRYJohn E. DavisChief Commercial OfficerOpen market sell$173K-1.9%$37.78$173KMar 3, 2026Mar 4, 2026
    CRYLance A. BerryEVP, COO, CFO & TreasurerOpen market sell$239K-2.9%$37.78$239KMar 3, 2026Mar 4, 2026
    CRYJames P. MackinPresident & CEOOpen market sell$676K-1.9%$37.78$676KMar 3, 2026Mar 4, 2026
    CRYAmy HortonVP, Chief Accounting OfficerOpen market sell$24.4K-0.5%$38.02$24.4KMar 2, 2026Mar 3, 2026
    CRYMarshall S. StantonSVP, Clinical & MD AffairOpen market sell$57.5K-3.6%$38.02$57.5KMar 2, 2026Mar 3, 2026
    CRYJames P. MackinPresident & CEOOpen market sell$567K-1.7%$38.02$567KMar 2, 2026Mar 3, 2026
    CRYJean F. HollowaySVP, General CounselOpen market sell$83K-1.3%$38.02$83KMar 2, 2026Mar 3, 2026
    CRYLance A. BerryEVP, COO, CFO & TreasurerOpen market sell$197K-2.9%$38.02$197KMar 2, 2026Mar 3, 2026
    CRYJohn E. DavisChief Commercial OfficerOpen market sell$106K-1.3%$38.02$106KMar 2, 2026Mar 3, 2026
    CRYAmy HortonVP, Chief Accounting OfficerOpen market sell$29.6K-0.7%$35.69$29.6KFeb 24, 2026Feb 25, 2026
    CRYMarshall S. StantonSVP, Clinical & MD AffairOpen market sell$44.9K-2.9%$35.69$44.9KFeb 24, 2026Feb 25, 2026
    CRYJean F. HollowaySVP, General CounselOpen market sell$59.5K-1.1%$35.69$59.5KFeb 24, 2026Feb 25, 2026
    CRYJames P. MackinPresident & CEOOpen market sell$497K-1.8%$35.69$497KFeb 24, 2026Feb 25, 2026
    CRYLance A. BerryEVP, COO, CFO & TreasurerOpen market sell$160K-3.0%$35.69$160KFeb 24, 2026Feb 25, 2026
    CRYJohn E. DavisChief Commercial OfficerOpen market sell$74.1K-1.1%$35.69$74.1KFeb 24, 2026Feb 25, 2026
    CRYAmy HortonVP, Chief Accounting OfficerOpen market sell$65.1K-1.3%$37.59$65.1KFeb 23, 2026Feb 25, 2026
    CRYMarshall S. StantonSVP, Clinical & MD AffairOpen market sell$91.1K-5.3%$37.59$91.1KFeb 23, 2026Feb 25, 2026
    CRYJean F. HollowaySVP, General CounselOpen market sell$116K-2.0%$37.59$116KFeb 23, 2026Feb 25, 2026
    CRYJames P. MackinPresident & CEOOpen market sell$788K-2.6%$37.59$788KFeb 23, 2026Feb 25, 2026
    CRYLance A. BerryEVP, COO, CFO & TreasurerOpen market sell$187K-3.3%$37.59$187KFeb 23, 2026Feb 25, 2026
    CRYJohn E. DavisChief Commercial OfficerOpen market sell$142K-1.9%$37.59$142KFeb 23, 2026Feb 25, 2026
    CRYJohn E. DavisChief Commercial OfficerOpen market sell$226K-2.5%$45.11$226KDec 15, 2025Dec 17, 2025
    CRYAmy HortonVP, Chief Accounting OfficerOpen market sell$203K-3.4%$44.42$203KDec 8, 2025Dec 9, 2025
    CRYJean F. HollowaySVP, General CounselOpen market sell$239K-3.3%$45.30$239KDec 3, 2025Dec 4, 2025
    CRYJean F. HollowaySVP, General CounselOpen market sell$92.8K-1.3%$45.30$92.8KDec 3, 2025Dec 4, 2025
    CRYElizabeth A. HoffDirectorOpen market sell$189K-13.4%$45.10$189KNov 18, 2025Nov 19, 2025
    CRYAmy HortonVP, Chief Accounting OfficerOpen market sell$274K-4.2%$45.73$274KNov 17, 2025Nov 18, 2025
    CRYAmy HortonVP, Chief Accounting OfficerOpen market sell$160K-2.4%$45.86$160KNov 13, 2025Nov 14, 2025
    CRYJohn E. DavisChief Commercial OfficerOpen market sell$301K-3.2%$45.86$301KNov 13, 2025Nov 14, 2025
    CRYJames P. MackinPresident & CEOOpen market sell$1.57M-4.1%$45.86$1.57MNov 13, 2025Nov 14, 2025
    CRYJean F. HollowaySVP, General CounselOpen market sell$264K-3.4%$45.86$264KNov 13, 2025Nov 14, 2025
    CRYMarshall S. StantonSVP, Clinical & MD AffairOpen market sell$229K-8.1%$45.86$229KNov 13, 2025Nov 14, 2025
    CRYJean F. HollowaySVP, General CounselOpen market sell$132K-1.7%$44.62$132KNov 10, 2025Nov 12, 2025
    CRYJames P. MackinPresident & CEOOpen market sell$784K-2.1%$44.62$784KNov 10, 2025Nov 12, 2025
    CRYJohn E. DavisChief Commercial OfficerOpen market sell$151K-1.6%$44.62$151KNov 10, 2025Nov 12, 2025
    CRYAmy HortonVP, Chief Accounting OfficerOpen market sell$79.8K-1.2%$44.62$79.8KNov 10, 2025Nov 12, 2025
    CRYMarshall S. StantonSVP, Clinical & MD AffairOpen market sell$114K-4.0%$44.62$114KNov 10, 2025Nov 12, 2025
    End of history · 48 transactions

    Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.